BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,990,027 | +192.5% | 856,034 | +268.1% | 0.02% | +214.3% |
| Q2 2023 | $14,696,212 | +563405.1% | 232,535 | +301.1% | 0.01% | +600.0% |
| Q1 2023 | $2,608 | -81.9% | 57,972 | -82.3% | 0.00% | -87.5% |
| Q4 2022 | $14,383 | -99.8% | 328,293 | +207.4% | 0.01% | +100.0% |
| Q3 2022 | $7,038,000 | +11.2% | 106,807 | -14.8% | 0.00% | +33.3% |
| Q2 2022 | $6,330,000 | -39.1% | 125,323 | -23.0% | 0.00% | -50.0% |
| Q1 2022 | $10,398,000 | +204.0% | 162,778 | +409.7% | 0.01% | +200.0% |
| Q4 2021 | $3,420,000 | -62.4% | 31,934 | -63.9% | 0.00% | -60.0% |
| Q3 2021 | $9,094,000 | -31.6% | 88,451 | -41.5% | 0.01% | -37.5% |
| Q2 2021 | $13,299,000 | -0.8% | 151,195 | +9.7% | 0.01% | -20.0% |
| Q1 2021 | $13,406,000 | +70.3% | 137,882 | +96.4% | 0.01% | +100.0% |
| Q4 2020 | $7,873,000 | -61.0% | 70,202 | -67.7% | 0.01% | -80.0% |
| Q3 2020 | $20,176,000 | +19.8% | 217,650 | +0.8% | 0.02% | +8.7% |
| Q2 2020 | $16,837,000 | +835.4% | 215,862 | +601.3% | 0.02% | +475.0% |
| Q1 2020 | $1,800,000 | -82.0% | 30,780 | -75.4% | 0.00% | -69.2% |
| Q4 2019 | $10,022,000 | -9.1% | 125,100 | -16.6% | 0.01% | -23.5% |
| Q3 2019 | $11,020,000 | -57.5% | 150,000 | -45.5% | 0.02% | -56.4% |
| Q2 2019 | $25,941,000 | +30.3% | 275,000 | +10.6% | 0.04% | +30.0% |
| Q1 2019 | $19,902,000 | +278.3% | 248,615 | +154.7% | 0.03% | +275.0% |
| Q4 2018 | $5,261,000 | -50.7% | 97,596 | -28.6% | 0.01% | -38.5% |
| Q3 2018 | $10,668,000 | +2117.9% | 136,659 | +1704.3% | 0.01% | +1200.0% |
| Q2 2018 | $481,000 | -91.9% | 7,574 | -88.2% | 0.00% | -87.5% |
| Q1 2018 | $5,906,000 | -47.0% | 64,410 | -59.7% | 0.01% | -52.9% |
| Q3 2017 | $11,139,000 | +3822.2% | 159,884 | +2151.9% | 0.02% | +1600.0% |
| Q1 2017 | $284,000 | -56.5% | 7,100 | -67.7% | 0.00% | 0.0% |
| Q3 2016 | $653,000 | -12.6% | 22,003 | -37.1% | 0.00% | 0.0% |
| Q3 2015 | $747,000 | -64.8% | 35,000 | -56.4% | 0.00% | -75.0% |
| Q2 2015 | $2,124,000 | – | 80,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |